PRMT5 and central nervous system cancer: Then, we simulated the inhibitory effect of PRMT5/MTA inhibitor on GBMs by in vitro and in vivo experiments in which MTAP‐deficient glioma cells coexisted with microglia and neurons with normal MTAP expression.